Interface Biologics, Inc.

101 College Street, Suite 300
Toronto, Ontario M5G 1L7 Canada
Phone
Fax
Click for website

Research Sector Medical Devices

Summary Description Advancing biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices

Management Thomas P. Reeves, President & C.E.O.; Defne Garner, Director, Finance; Dr. Roseita Esfand, Ph.D., Director, Research & Development; Jeannette Ho, M.A.Sc., Director of Operations; Dr. Paul Santerre, Ph.D., Chief Scientific Officer; Mark Steedman, Vice President, Business Development

Click here for Financial Data
Keywords: medical devices, biomedical polymer technology, anti-thrombogenic, DrugDelivery, anti-infection, angioplasty, Cardiology, medical implants, cardiovascular

Comment


Updated: May 07, 2017


Description

Interface Biologics (IBI) is a specialty biotech company that has developed a cutting edge surface material platform for use in medical devices, which provides them with superior performance propertie......view more

Products / Services

Endexo: anti-thrombogenic additives: vascular access catheters, PVC tubing, dialyzers, vascular grafts, filter housing. Epidel anti-infective polymers: percutaneous anti-infective cuff, orthopedic ......view more

Technology / Differentiation

Interface has developed three specific biomedical polymer technology platforms. Endexo can be added to standard coatings to prevent platelet aggregation and the formation of blood clots around imp...view more

Market / Customers

Medical devices which require anti-thombogenic or anti-fouling properties; combination drug delivery devices Endexo, Kinesyx and Epidel are applicable to a wide range of biomedical devices (cathete......view more


Competitors / Substitutes / Alternatives

Manufacters of heparin-based anti-thrombogenic coatings: AST Products, Inc., Cordis Corporation (subsidiary of Johnson & Johnson), Medi-Solve Coatings LLC, and BioInteractions Ltd. Non-heparin base...view more

Status

Licensing partner AngioDynamics received FDA Clearance for BioFloTM PICC with EndexoTM technology, September 2012...view more

Advisors

Companys Law Firm corporate: Oslers; IP: Clark & Elbing; commercial: Wilson, Sonsini, Goodrich & Rosati Companys Banker none engaged at this time Companys Accounting Firm...view more

RELATED COMPANIES



0000-00-00-6372